Latest Breaking News On - Senic group - Page 1 : vimarsana.com

BioSenic provides First Quarter 2024 Business Update

BioSenic provides First Quarter 2024 Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nord pas de calaisFrance generalMont saint guibertWaals gewestCarole niccoMedsenic biosenicBiosenic groupCanadian intellectual property officeEuronext brusselsGlobal tech opportunitiesChief operating officerChief scientific officerLicense agreementMedsenic phaseSenic groupLouvain la neuve science park

Interview: Daniel Levy still doesn t appreciate Tottenham s culture

Tottenham author and influential football industry figure Alex Fynn on Enic and Levy's reign, takeover rumours and his new book.

France generalUnited kingdomUnited statesNuno espirito santoGary mabbuttJermaine defoeMartin chiversAnge postecoglou tottenhamAntonio conteFrank dalleresJoe lewisIrving scholarAlex fynnBrian cloughPat jenningsMichael dawson

BioSenic reports half year 2023 results

BioSenic reports half year 2023 results
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Walloon regionWaals gewestFrance generalMont saint guibertCarole niccoSeitosei actifinGhislaine gasparettoYves brulardEnrico bastianelliNeil hunter michelle boxallYves sagotLieven huysseNeither the companyOwners of the companyBiosenic groupIb communications

BioSenic provides first quarter 2023 business update

BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces its business update for the first quarter, ended 31 March 2023. Key highlights. Strengthening of Executive Committee and Board of Directors with the .

France generalMont saint guibertWaals gewestBiosenic groupEuronext brusselsExecutive committeeChief scientific officerChief medical officerYves sagotMarketing authorizationMarketing authorization applicationConvertible bondsSenic groupArsenic trioxideHost diseaseSystemic sclerosis

BioSenic provides First Quarter 2023 Business Update

REGULATED INFORMATION ALLOB Phase IIb topline results foreseen in July/August 2023Ongoing discussions for key partnerships with lead clinical assets Mont-Saint-Guibert, Belgium, May 22nd,. | May 22, 2023

France generalMont saint guibertWaals gewestSeitosei actifinNeil hunter michelle boxallBert bouserieGhislaine gasparettoAnnie florence loyerIb communicationsBiosenic groupInternational media enquiriesEuronext brusselsExecutive committeeChief scientific officerChief medical officerYves sagot